Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation

Zheng, XT; Luo, JM; Liu, W; Ashby, CR; Chen, ZS; Lin, LZ

Lin, LZ (通讯作者),Guangzhou Univ Chinese Med, Canc Ctr, Affiliated Hosp 1, Guangzhou, Peoples R China.;Chen, ZS (通讯作者),St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, New York, NY 11439 USA.

DRUGS OF TODAY, 2022; 58 (4): 175

Abstract

Sotorasib, a direct inhibitor of the enzyme Kirsten rat sarcoma viral oncogene (KRAS) with the G12C mutation, was approved by the U.S. Food and Drug A......

Full Text Link